Resistance to antimicrobials and combination therapy assessment in neonatal sepsis;Resistencia a antimicrobianos y evaluación del tratamiento combinado en la septicemia neonatal

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 13, Issue 4, 2003, Pages 214-221

  Espino Hernández, María ^a   Couto Ramos, María Julia ^b   Fiol Ferrer, Niurka ^b   Rojas Hernández, Nidia ^c  

^a Escuela Latinoamericana de Medicina   (Cuba)

^b HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

^c UNIVERSITY OF HAVANA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZLOCILLIN; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; GENTAMICIN; GLYCOPEPTIDE; KANAMYCIN; METICILLIN; OXACILLIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTICS; BACTERIUM; DRUG RESISTANCE; HEALTH MONITORING;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL PROTOCOL; CRITICAL ILLNESS; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENTIATION; ENTEROCOCCUS FAECIUM; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; NONHUMAN; STAPHYLOCOCCUS; TECHNIQUE; TREATMENT FAILURE;

CUBA;

EID: 0038560039     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892003000300003     Document Type: Article

References (26)

1. Schmidt BK, Kirpalani HM, Corey M, Low DE, Philip AGS, Ford-Jones EL. Coagulase-negative staphylococci as true pathogens in newborn infants: a cohort study. Pediatr Infect Dis J 1987;6:1026-1031.
2. Montero RA, Álvarez TM, Barbadillo FI, Carpintero IM, Sastre EH, Alonso BA. Análisis de sepsis por estafilococo coagulasa negativo en una unidad neonatal. Acta Pediatr Esp 1998;56:182-186.
3. Kollef MH. Antibiotic resistance among Gram-positive bacteria in the hospital setting: what can we do about it? [Sitio en Internet] Medscape, Inc. Disponible en http://www.medscape.com/viewprogram/623. Acceso el 10 de diciembre de 2002.
4. Wolff MJ. Use and misuse of antibiotics in Latin America. Clin Infec Dis 1993;17(Supl 2):S346-S351.
5. Espino M, Couto MJ, Lee M, Páez N, Meriño E. Efecto sinérgico de penicilina G y kanamicina en septicemia neonatal por estafilococos. Rev Cubana Pediatr 1995;67:155-164.
6. Berenbaum MC. A method for testing for synergy with any number of agents. J Infect Dis 1978;137:122-130.
7. National Committee for Clinical Laboratory Standards. Method for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Wayne, Pa.: NCCLS; 1993. (Document M7-A3, Supplement 1).
8. Matsumoto Y. Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection. Chemotherapy 1998;44 (Suppl 1):6-9.
9. Otsuka Y, Yoshibe T, Namioka M, Ezaki T. Combination effect of teicoplanin and beta-lactams on MRSA. Jpn J Antibiot 2000;53:643-651.
10. Kiri N, Archer G, Climo MW. Combination of lysostaphin with beta-lactams is synergistic against oxacillin resistant Staphylococcus epidermidis. Antimicrob Agents Chemother 2002; 46:2017-2020.
11. a ed. México, DF: Panamericana; 1992.
12. Sigarroa A. Biometría y diseño experimental. La Habana: Pueblo y Educación; 1985.
13. Rodríguez JC, Fraga JM, García RC, Fernández-Lorenzo JR, Martínez IC. Sepsis neonatal: indicadores epidemiológicos en relación con el peso del recién nacido y el tiempo de hospitalización. An Esp Pediatr 1998;48:401-408.
14. Leibovitz E, Fidel-Rimon O, Juster-Reicher A, Amitay M, Miskin A, Barak Y, et al. Sepsis at a neonatal intensive care unit: a four vear retrospective study (1989-1992). Isr J Med Sci 1997;33:734-738.
15. Brumfitt W, Hamilton-Miller JMT. The challenge of methicillin-resistant Staphylococcus aureus. Drugs Exp Clin Res 1994;20:215-224.
16. Niebla A, Espino M, González I, Otero I, Lemus M, González L, et al. Oxacillin resistance in Staphylococcus clinical isolates from Havana City Hospital, Cuba. Rev CENIC 2001;32:33-36.
17. Torvaldsen S, Roberts C, Riley TV. The continuing evolution of methicillin-resistant Staphylococcus aureus in Western-Australia. Infect Control Hosp Epidemiol 1999;20:133-135.
18. Asada K, Inoba Y, Tateda E, Kuwahara AK, Ito I, Imaratsu K. Evolution and resistance expression of MRSA isogenic strains with different types of phenotypic expressions. Acta Biochem Pol 1995;42:517-524.
19. Krediet TG, Jones ME, Gerards LJ, Fleer A. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates. Pediatrics 1999;103:E29.
20. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992;72:195-198.
21. Martone WJ. Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998;19:539-545.
22. Goossens H. Spread of vancomycin-resistant enterococci: differences between the United States and Europe. Infect Control Hosp Epidemiol 1998;19:546-551.
23. Holm SE. Interaction between beta-lactam and other antibiotics. Rev Infect Dis 1986;8 (Supl 3):S305-S314.
24. Predari SC, Gutiérrez MA, Ribas C, Molinari GS, Santoianni JE. Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays and high-level aminoglycoside resistance in a university hospital in Argentina. Rev Argent Microbiol 1991;23:67-78.
25. Moellering RC Jr. Antimicrobial synergism: an elusive concept. J Infect Dis 1979;140:639-641.
26. Espino M, Fiol N, Lee M, Couto MJ. Tratamiento con azlocilina y amikacina en sepsis neonatal por Staphylococcus haemolyticus multirresistente. Rev Cubana Pediatr 2000;72:60-64.